Avisa Diagnostics Inc.
Avisa Diagnostics Inc. (FOGCF) Company Profile & Overview
Explore Avisa Diagnostics Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Avisa Diagnostics Inc. (FOGCF) Company Profile & Overview
Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Santa Fe, New Mexico.